#United States #StimLabs #Wound Care #Roswell #Architect Fx

StimLabs Launches Architect: A New Frontier in Wound Care

StimLabs, a prominent player in regenerative medicine, recently announced the introduction of Architect Fx, an advanced extracellular collagen matrix designed specifically for effective wound management. This groundbreaking product is derived from equine pericardium and aims to address the needs of patients with various wound types, especially those that are challenging to heal.

Meeting Clinical Needs

As stated by John Daniel, the Founder and CEO of StimLabs, the company is committed to staying at the forefront of technology to address real clinical requirements. The launch of Architect Fx highlights this commitment, allowing healthcare providers to treat a broader range of patients who suffer from complex wounds. The innovative device aligns with StimLabs’ mission to deliver high-quality solutions that make a significant impact on patient care.

Wide Application Range

Architect Fx has received FDA 510(k) clearance, enabling its use for numerous hard-to-heal wounds. This includes chronic diabetic wounds, venous and pressure ulcers, traumatic injuries, and surgical wounds. The product incorporates the proprietary BriDGE® technology which enhances stability and integrity, ensuring minimal degradation in the wound environment. This stability supports reapplications and allows extended wear, thereby giving clinicians the flexibility to tailor treatments based on the patient's healing progress.

Focused on Flexibility and Control

According to Tom Dion, EVP and Chief Commercial Officer of StimLabs, Architect Fx combines durability with clinical efficiency, empowering providers with enhanced control over complex wound management. The product is thoughtfully designed to benefit both patients and their healthcare providers, reinforcing StimLabs' position as a leader in advanced wound care solutions.

Future Plans

StimLabs plans to begin the distribution of Architect Fx in the first quarter of 2026, making it accessible to healthcare professionals across various settings. This strategic move is part of their larger plan to expand their commercial footprint and product portfolio, enhancing their service to the healthcare community and patients.

About StimLabs

StimLabs operates at the cutting edge of regenerative medicine, focusing primarily on wound care and surgical applications. The company is revered for its commitment to offering the best possible care to patients while addressing urgent clinical needs with effective solutions. With a strong portfolio of products and a well-established intellectual property catalog, StimLabs continues to be a trusted partner for both physicians and patients, working tirelessly to advance the standards of care in the industry.

For more details, visit StimLabs.